Pharmaceutical

Boehringer Ingelheim and Salipro enter drug discovery partnership

Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement for drug targets' development.

Mar 15, 2025 - 06:00
Boehringer Ingelheim and Salipro enter drug discovery partnership
Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement for drug targets' development.
Read the original article

Tags:

Previous Article

AstraZeneca director says AI must be a “thought partner” in drug discovery

Next Article

MeiraGTx and Hologen launch AI-backed gene therapy venture

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

PDS-01ADC by PDS Biotechnology for Colorectal Cancer: Likelihood of Approval

PDS-01ADC by PDS Biotechnology for Colorectal Cancer: L...

Jan 3, 2024

Lilly gains US FDA approval for Omvoh to treat Crohn’s disease

Lilly gains US FDA approval for Omvoh to treat Crohn’s ...

Jan 16, 2025

CDC advisory panel recommends seniors ‘may’ get RSV vaccine

CDC advisory panel recommends seniors ‘may’ get RSV vac...

Jun 22, 2023